{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "from pysb import *\n",
    "from pysb.macros import bind\n",
    "from pysb.macros import degrade\n",
    "import pysb.pkpd as pkpd\n",
    "from pysb.simulator import ScipyOdeSimulator\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Compartmental Models in Pharmacokinetics: A Concise Summary\n",
    "\n",
    "Pharmacokinetics describes how drugs move through the body. One way to analyze this movement is with compartmental models, which imagine the body as a series of interconnected compartments. Each compartment represents a group of tissues with similar drug distribution properties.\n",
    "\n",
    "**Different models for different complexities:**\n",
    "\n",
    "* **One-compartment model:** Simplest model, assuming the drug distributes quickly and uniformly throughout the body (e.g., water-soluble drugs).\n",
    "* **Two-compartment model:** Splits the body into a central compartment (blood and well-perfused organs) and a peripheral compartment (less perfused tissues). Useful for drugs that take longer to reach certain tissues.\n",
    "* **Three-compartment model:** Adds a second peripheral compartment for drugs with multiple distribution phases or slower penetration into certain tissues.\n",
    "\n",
    "**Key points to remember:**\n",
    "\n",
    "* Compartments are theoretical constructs for studying drug distribution, not actual anatomical units.\n",
    "* Choosing the right model depends on the drug's distribution properties and plasma concentration-time profile.\n",
    "* Some models include an \"Effect compartment\" to link drug concentration with its actual effects.\n",
    "* More complex models, like PBPK, use many compartments to represent detailed tissue-specific distribution.\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### PK Concept\n",
    "\n",
    "1. **Dose/Dosage**: \n",
    "   - _Dose_ refers to the amount of drug administered at a specific time.\n",
    "   - _Dosage_ is about multiple doses taken over time with a set frequency.\n",
    "   - The route of administration (e.g., oral vs. intravenous) is vital in determining the appropriate dose or dosage.\n",
    "\n",
    "2. **Bioavailability ($\\beta$)**: \n",
    "   - Represents the fraction of a drug dose that gets absorbed and reaches the action site.\n",
    "   - Particularly relevant for oral administration, where not all the drug enters the circulation.\n",
    "\n",
    "3. **Volume of Distribution ($V_d$)**: \n",
    "   - A theoretical volume in which a drug is distributed to yield a measured plasma concentration.\n",
    "   - Provides insights into whether a drug stays in plasma or disperses into tissues.\n",
    "   - Not a fixed value and varies depending on the compartment model used.\n",
    "\n",
    "4. **Elimination**: \n",
    "   - The process of removing the drug from the body, typically through metabolism and excretion.\n",
    "   - Often modeled as a linear process with first-order kinetics.\n",
    "\n",
    "5. **Clearance (CL)**: \n",
    "   - Defined as the volume of plasma cleared of the drug per unit time.\n",
    "   - Can also be expressed as the rate of drug elimination divided by the drug's plasma concentration.\n",
    "   - In compartmental models, clearance is linked with a first-order rate constant.\n",
    "\n",
    "### PD Functions:\n",
    "\n",
    "1. **Emax**: \n",
    "   - Relates drug concentration to effect using a non-linear sigmoid function.\n",
    "   - Described as $E = E_{max} \\left[Drug\\right] / (\\left[Drug\\right] + EC_{50})$, where $E_{max}$ is the maximum effect and $EC_{50}$ is the half-maximum concentration.\n",
    "   - Can include a baseline effect, modifying the equation accordingly.\n",
    "\n",
    "2. **Sigmoidal Emax**: \n",
    "   - A generalized form of the Emax function.\n",
    "   - Expressed as $E = E_{max} \\left[Drug\\right]^n / (\\left[Drug\\right]^n + EC_{50}^n)$, with $n$ being the Hill slope.\n",
    "   - Can also account for a baseline effect.\n",
    "\n",
    "Other PD functions include:\n",
    "   \n",
    "- **Linear Effect Model**: Direct linear relationship between drug concentration and effect.\n",
    "- **Log-linear Effect Model**: Effect varies linearly with the logarithm of drug concentration.\n",
    "- **Fixed-Effect Model**: Fixed effect magnitude occurring beyond a certain drug concentration threshold."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "PD-1, short for Programmed Death-1, is a protein that plays a significant role in regulating the immune system's response to cells in the human body. It is a type of protein known as a checkpoint protein, which is found on the surface of certain immune cells called T cells. \n",
    "\n",
    "### Function:\n",
    "PD-1 acts as an immune checkpoint, meaning it is crucial in preventing the immune system from attacking normal cells in the body. It does this by delivering inhibitory signals to the T cells when it binds to its ligands (PD-L1 or PD-L2), which are often found on the surface of healthy cells. This interaction effectively tells the T cells to ignore the normal, healthy cells, thus preventing an autoimmune response.\n",
    "\n",
    "### Clinical Significance:\n",
    "1. **Cancer Therapy**: Many cancer cells express PD-L1, the ligand for PD-1, allowing them to evade the immune system by inhibiting T cell function. This has led to the development of PD-1 inhibitors, a class of drugs called immune checkpoint inhibitors, used in cancer immunotherapy. These drugs block PD-1, preventing it from binding to PD-L1 on cancer cells, thereby enabling the immune system to recognize and destroy these cancer cells.\n",
    "\n",
    "2. **Autoimmune Diseases**: Since PD-1 plays a role in preventing autoimmune reactions, it is also of interest in the study and treatment of autoimmune diseases. Alterations in the PD-1 pathway can contribute to the development of autoimmune disorders.\n",
    "\n",
    "### Examples of PD-1 Inhibitors:\n",
    "- Pembrolizumab (Keytruda)\n",
    "- Nivolumab (Opdivo)\n",
    "\n",
    "These inhibitors have been successful in treating various types of cancer, including melanoma, non-small cell lung cancer, and more, by enhancing the immune system's ability to fight cancer."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Summary of the case study on Pembrolizumab (Pembro) and its target occupancy modeling:\n",
    "[Study on Pembrolizumab (Pembro) and Target Occupancy](https://info.appliedbiomath.com/hubfs/Case%20Studies/Applied%20BioMath_Inferring%20TO_Pembro_Case%20Study.pdf)\n",
    "### Background\n",
    "- **Drug**: Pembrolizumab (Pembro), an anti-PD-1 antibody.\n",
    "- **Indications**: Approved for various cancer treatments.\n",
    "- **Dosage**: Administered as 200 mg or 2 mg/kg intravenously every three weeks (Q3W).\n",
    "- **Challenge**: Determining the percent target receptor occupancy (RO) for PD-1, which is difficult through direct experimental measurements.\n",
    "\n",
    "### Results\n",
    "- **Model Development**: A semi-mechanistic Pharmacokinetic Receptor Occupancy (PKRO) model was created to fit phase 1 PK data of Pembro.\n",
    "- **RO Predictions**: The model predicted that varying the concentration of soluble PD-1 (sPD-1) does not significantly affect PD-1 RO in the tumor for the clinically approved dose of 2 mg/kg Q3W.\n",
    "- **Parameter Sensitivity**: Exploring the impact of Kd (dissociation constant) and the drug:PD-1 turnover rate. The model remained robust (> 90% RO) even when these parameters varied by 10-fold.\n",
    "\n",
    "### Model Diagram and Mechanics\n",
    "- **Compartments**: The Quantitative Systems Pharmacology (QSP) model incorporated three compartments - tumor, circulation (Central), and other organs/tissues (Peripheral).\n",
    "- **Mechanisms**:\n",
    "  1. Binding of the drug to PD-1 and sPD-1.\n",
    "  2. PD-1 receptor turnover.\n",
    "  3. Internalization and clearance of the drug:PD-1 complex.\n",
    "  4. Clearance of free drug and drug:sPD-1 complex.\n",
    "- **PD-L1 Expression**: Limited to the tumor compartment.\n",
    "\n",
    "### Conclusion\n",
    "- **PD-1 Expression**: Predicted to be around 10.8 pM in circulation without soluble PD-1. Higher expression is predicted in the presence of sPD-1, reflecting non-linear PK.\n",
    "- **RO Predictions**: \n",
    "  - For 2 mg/kg IV Q3W dosing, Pembro showed > 98% RO in the tumor compartment across different sPD-1 concentrations.\n",
    "  - Variations in Kd or the half-life of the mAb-PD1 complex did not significantly impact the high level of PD-1 occupancy (> 90% at steady state) with the standard 2 mg/kg Q3W dose. \n",
    "\n",
    "This model serves as an important tool for dose selection in anti-PD-1 combination studies and the development of other anti-PD-1 drugs."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Model 'pembro_pd' (monomers: 0, rules: 0, parameters: 0, expressions: 0, compartments: 0, energypatterns: 0) at 0x1610d8850>"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Model(name='pembro_pd')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "ComponentSet([\n",
       " Compartment(name='CENTRAL', parent=None, dimension=3, size=V_CENTRAL),\n",
       " Compartment(name='PERIPHERAL', parent=None, dimension=3, size=V_PERIPHERAL),\n",
       " Compartment(name='TUMOR', parent=None, dimension=3, size=V_TUMOR),\n",
       " Parameter('V_CENTRAL', 1.0),\n",
       " Parameter('V_PERIPHERAL', 1.0),\n",
       " Parameter('V_TUMOR', 1.0),\n",
       " ])"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pkpd.three_compartments(c3_name='TUMOR')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "In PySB, a monomer is a basic building block used to model a molecule, typically a protein or a drug. Monomers can have binding sites that allow them to interact with other monomers, forming complexes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Monomer('Pembro', ['b'])"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Monomer(\"Pembro\", ['b'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Monomer('PD1', ['b'])"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Monomer(\"PD1\", ['b'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Monomer('sPD1', ['b'])"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Monomer(\"sPD1\", ['b'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Monomer('PDL1', ['b'])"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Monomer(\"PDL1\", ['b'])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "pkpd.distribute is a function provided by the PySB pkpd extension. This function is used to model the reversible transfer of a substance (like a drug) between two different compartments in a PK/PD model."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "ComponentSet([\n",
       " Rule('distribute_Pembro_CENTRAL_to_TUMOR', Pembro(b=None) ** CENTRAL | Pembro(b=None) ** TUMOR, distribute_Pembro_CENTRAL_to_TUMOR_kf, distribute_Pembro_CENTRAL_to_TUMOR_kr),\n",
       " Parameter('distribute_Pembro_CENTRAL_to_TUMOR_kf', 2e-06),\n",
       " Parameter('distribute_Pembro_CENTRAL_to_TUMOR_kr', 6e-05),\n",
       " ])"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pkpd.distribute(Pembro(b=None), CENTRAL, PERIPHERAL, [5e-5, 1e-3])\n",
    "pkpd.eliminate(Pembro(b=WILD), CENTRAL, 3e-6) \n",
    "pkpd.distribute(Pembro(b=None), CENTRAL, TUMOR, [2e-6, 6e-5])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    " **Arguments of the `bind` Function:**\n",
    "   - `Pembro`: This is the first monomer in the binding interaction, representing Pembrolizumab. It has a binding site labeled 'b'.\n",
    "   - `'b'`: This is the name of the binding site on Pembrolizumab where the interaction will occur.\n",
    "   - `PD1`: The second monomer, representing the PD1 receptor, which Pembrolizumab will bind to. It also has a binding site named 'b'.\n",
    "   - `'b'`: This is the name of the binding site on the PD1 receptor.\n",
    "   - `[5e-4, 8e-3]`: These are the kinetic rate constants for the binding interaction. The first value (`5e-4`) is the forward rate constant for the binding of Pembro to PD1, and the second value (`8e-3`) is the reverse rate constant for the dissociation of the Pembro-PD1 complex."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "ComponentSet([\n",
       " Rule('bind_PD1_PDL1', PD1(b=None) ** TUMOR + PDL1(b=None) ** TUMOR | PD1(b=1) ** TUMOR % PDL1(b=1) ** TUMOR, bind_PD1_PDL1_kf, bind_PD1_PDL1_kr),\n",
       " Parameter('bind_PD1_PDL1_kf', 1e-07),\n",
       " Parameter('bind_PD1_PDL1_kr', 0.01),\n",
       " ])"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "bind(Pembro, 'b', PD1, 'b', [5e-4, 8e-3])\n",
    "bind(Pembro, 'b', sPD1, 'b', [5e-4, 8e-3])\n",
    "bind(PD1(b=None)**TUMOR, 'b', PDL1(b=None)**TUMOR, 'b', [1e-7, 1e-2])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "pd1_all = (PD1(b=None)**CENTRAL + PD1(b=None)**PERIPHERAL + PD1(b=None)**TUMOR)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Rule('PD1_synth', None >> PD1(b=None) ** CENTRAL + PD1(b=None) ** PERIPHERAL + PD1(b=None) ** TUMOR, k_PD1_synth)"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#zero-order rate constant for the synthesis of PD1 protein\n",
    "Parameter(\"k_PD1_synth\", 3e-6)\n",
    "#rule for the synthesis of PD1 protein\n",
    "Rule(\"PD1_synth\", None >> pd1_all, k_PD1_synth)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "ComponentSet([\n",
       " Rule('degrade_PD1WILD', PD1(b=WILD) >> None, degrade_PD1WILD_k),\n",
       " Parameter('degrade_PD1WILD_k', 3e-06),\n",
       " ])"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "degrade(PD1(b=WILD), 3e-6)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "ComponentSet([\n",
       " Rule('absorb_Pembro_CENTRAL', Pembro_CENTRAL_precursor() ** CENTRAL >> Pembro(b=None) ** CENTRAL, absorb_Pembro_CENTRAL_ka),\n",
       " Parameter('absorb_Pembro_CENTRAL_ka', 0.003),\n",
       " Parameter('dose_Pembro_CENTRAL', 2000.0),\n",
       " Expression('expr_Pembro_CENTRAL_dose', dose_Pembro_CENTRAL/V_CENTRAL),\n",
       " Parameter('ka_Pembro_CENTRAL', 0.003),\n",
       " Parameter('F_Pembro_CENTRAL', 1.0),\n",
       " Monomer('Pembro_CENTRAL_precursor'),\n",
       " ])"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pkpd.dose_absorbed\n",
    "pkpd.dose_absorbed(Pembro(b=None), CENTRAL, 2000.0, 3e-3, 1.0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/latex": [
       "$\\displaystyle Pembro_{PERIPHERAL}$"
      ],
      "text/plain": [
       "Observable('Pembro_PERIPHERAL', Pembro(b=WILD) ** PERIPHERAL)"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Parameter('PD1_CP0', 0.1)\n",
    "Initial(PD1(b=None)**CENTRAL, PD1_CP0)\n",
    "Initial(PD1(b=None)**PERIPHERAL, PD1_CP0)\n",
    "Parameter('PD1_T0', 0.083)\n",
    "Initial(PD1(b=None)**TUMOR, PD1_T0)\n",
    "\n",
    "Parameter('sPD1_0', 0.0415)\n",
    "Initial(sPD1(b=None)**CENTRAL, sPD1_0)\n",
    "Initial(sPD1(b=None)**PERIPHERAL, sPD1_0)\n",
    "Initial(sPD1(b=None)**TUMOR, sPD1_0)\n",
    "\n",
    "Parameter('PDL1_0', 0.010)\n",
    "Initial(PDL1(b=None)**TUMOR, PDL1_0)\n",
    "\n",
    "Observable(\"Pembro_PD1_TUMOR\", Pembro(b=ANY)**TUMOR % PD1(b=ANY)**TUMOR)\n",
    "Observable(\"PD1_TUMOR\", PD1(b=WILD)**TUMOR)\n",
    "Expression(\"RO_TUMOR\", 100 * Pembro_PD1_TUMOR / PD1_TUMOR) \n",
    "Observable(\"Pembro_CENTRAL\", Pembro(b=WILD)**CENTRAL)\n",
    "Observable(\"Pembro_TUMOR\", Pembro(b=WILD)**TUMOR)\n",
    "Observable(\"Pembro_PERIPHERAL\", Pembro(b=WILD)**PERIPHERAL)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "ld: warning: duplicate -rpath '/Users/tbin/anaconda3/envs/explore/lib' ignored\n"
     ]
    }
   ],
   "source": [
    "sim = ScipyOdeSimulator(pembro_pd)\n",
    "tspan = np.arange(0, 86400 * 8, 10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "out = sim.run(tspan=tspan).all"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([  0.        ,  59.09265255, 116.40667235, ..., 271.38325107,\n",
       "       271.37572316, 271.36819546])"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "out['Pembro_CENTRAL']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_out=pd.DataFrame(out)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['__s0', '__s1', '__s2', '__s3', '__s4', '__s5', '__s6', '__s7', '__s8',\n",
       "       '__s9', '__s10', '__s11', '__s12', '__s13', '__s14', '__s15', '__s16',\n",
       "       '__s17', 'Pembro_PD1_TUMOR', 'PD1_TUMOR', 'Pembro_CENTRAL',\n",
       "       'Pembro_TUMOR', 'Pembro_PERIPHERAL', 'RO_TUMOR'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_out.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_out['']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "69120"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(tspan / 86400)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['__s0', '__s1', '__s2', '__s3', '__s4', '__s5', '__s6', '__s7', '__s8',\n",
       "       '__s9', '__s10', '__s11', '__s12', '__s13', '__s14', '__s15', '__s16',\n",
       "       '__s17', 'Pembro_PD1_TUMOR', 'PD1_TUMOR', 'Pembro_CENTRAL',\n",
       "       'Pembro_TUMOR', 'Pembro_PERIPHERAL', 'RO_TUMOR'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_out.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "tspan_day = tspan / 86400\n",
    "plt.plot(tspan_day, out['Pembro_CENTRAL'], label='Central')\n",
    "plt.plot(tspan_day, out['Pembro_PERIPHERAL'], label='Peripheral')\n",
    "plt.plot(tspan_day, out['Pembro_TUMOR'], label='Tumor')\n",
    "plt.xlabel(\"Time (days)\")\n",
    "plt.ylabel(\"Concentration (nM)\")\n",
    "plt.legend(loc=0)\n",
    "plt.yscale('log')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "https://www.mathworks.com/help/simbio/ug/generate-virtual-population.html#VirtualPatientsSimBiologyModelAnalyzerExample-6"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "explore",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
